Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 304,162 shares at $50.00 ($15.2M) on 2020-10-05, disclosed to the SEC on 2020-10-07.
Open-market sale of $15.2M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 900 | $45K | 0.3% |
| 2 | $50.00 | 54,560 | $2.7M | 17.9% |
| 3 | $50.10 | 50,015 | $2.5M | 16.4% |
| 4 | $50.10 | 50,015 | $2.5M | 16.4% |
| 5 | $50.14 | 51,825 | $2.6M | 17.1% |
| 6 | $50.14 | 51,825 |
| $2.6M |
| 17.1% |
| 7 | $50.15 | 22,511 | $1.1M | 7.4% |
| 8 | $50.15 | 22,511 | $1.1M | 7.4% |
| Total | $50.10 avg | 304,162 | $15.2M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |